Fatigue is an exceedingly common often treatable problem in cancer patients that
profoundly affects all aspects of quality of life. Prevalence estimates have ranged from 50 …

Background Cancer survivors suffer from health deficits caused by their disease and
treatment. This study conducted a systematic review and meta-analysis on how, and to what …

BACKGROUND: As patients with pancreas and periampullary cancer (PPC) experience
improved survival rates and longevity, the focus shifts toward living life while surviving …

Cancer-related fatigue is a pervasive syndrome experienced by a majority of cancer patients
undergoing treatment, and muscular dysfunction may be a key component in the …

Cancer-related fatigue is the most prevalent cancer symptom, reported in 50%-90% of
patients and severely impacts quality of life and functional capacity. The condition remains …

Background Cancer-related fatigue (CRF) is well documented in cancer survivors, but little is
known about the personal and societal impact of CRF. This study aimed to examine the …

A fadiga relacionada ao câncer (FRC) é um dos sintomas mais prevalentes em pacientes
com câncer, sendo reportada por 50% a 90% dos pacientes durante o curso da doença ou …

Purpose To identify, describe, and organise currently available evidence regarding systemic
oncological treatments (SOTs)(chemotherapy, targeted/biological therapies, and …

With improved survival after hematopoietic cell transplantation (HCT), the number of
individuals at risk for persistent or late effects is increasing. The importance of optimizing …

Background: Cancer-related fatigue (CRF) affects a majority of patients (pts) with symptoms
lasting up to several years after finishing therapy. These symptoms lead to decreased health …